- Home
- PAPL vs PRFX Comparison
PAPL vs PRFX Comparison
Compare PAPL & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAPL
- PRFX
- Stock Information
- Founded
- PAPL 2015
- PRFX 2007
- Country
- PAPL Canada
- PRFX Israel
- Employees
- PAPL N/A
- PRFX N/A
- Industry
- PAPL Finance: Consumer Services
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- PAPL Finance
- PRFX Health Care
- Exchange
- PAPL Nasdaq
- PRFX Nasdaq
- Market Cap
- PAPL 2.8M
- PRFX 3.8M
- IPO Year
- PAPL 2023
- PRFX 2020
- Fundamental
- Price
- PAPL $0.11
- PRFX $1.94
- Analyst Decision
- PAPL Strong Buy
- PRFX Hold
- Analyst Count
- PAPL 2
- PRFX 1
- Target Price
- PAPL $5.25
- PRFX N/A
- AVG Volume (30 Days)
- PAPL 2.7M
- PRFX 3.8M
- Earning Date
- PAPL 04-14-2025
- PRFX 05-14-2025
- Dividend Yield
- PAPL N/A
- PRFX N/A
- EPS Growth
- PAPL N/A
- PRFX N/A
- EPS
- PAPL N/A
- PRFX N/A
- Revenue
- PAPL $2,848,365.00
- PRFX N/A
- Revenue This Year
- PAPL $7.18
- PRFX N/A
- Revenue Next Year
- PAPL $25.02
- PRFX N/A
- P/E Ratio
- PAPL N/A
- PRFX N/A
- Revenue Growth
- PAPL 13.01
- PRFX N/A
- 52 Week Low
- PAPL $0.11
- PRFX $0.43
- 52 Week High
- PAPL $2.10
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- PAPL 18.51
- PRFX 35.86
- Support Level
- PAPL $0.11
- PRFX $2.22
- Resistance Level
- PAPL $0.15
- PRFX $2.41
- Average True Range (ATR)
- PAPL 0.03
- PRFX 0.15
- MACD
- PAPL -0.01
- PRFX -0.00
- Stochastic Oscillator
- PAPL 5.21
- PRFX 12.07
About PAPL Pineapple Financial Inc.
Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.